Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2014, 1(1): 52-56    
  本期目录 | 过刊浏览 | 高级检索 |
Robotic assisted laparoscopic simple suprapubic prostatectomy—The Smith Institute for urology experience with an evolving technique
Sammy E. Elsamra, Nikhil Gupta, Haris Ahmed, David Leavitt, Jessica Kreshover, Louis Kavoussi, Lee Richstone
The Smith Institute for Urology, New Hyde Park, New York, USA
Robotic assisted laparoscopic simple suprapubic prostatectomy—The Smith Institute for urology experience with an evolving technique
Sammy E. Elsamra, Nikhil Gupta, Haris Ahmed, David Leavitt, Jessica Kreshover, Louis Kavoussi, Lee Richstone
The Smith Institute for Urology, New Hyde Park, New York, USA
下载:  PDF (1415KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 Objective: Despite a multitude of minimally invasive surgical options available for benign prostatic enlargement, open simple prostatectomy (OSP) remains the standard for large prostates (typically greater than 100 g).OSP, however, is associated with significant morbidity.Recently, a few reports touting robotic application to simple prostatectomy have been published.Herein, we reviewed our series of robotic assisted laparoscopic simple suprapubic prostatectomy (RALSSP) and detailed modifications in our technique as our experience increased.Methods: All RALSSP cases performed between January 2013 and January 2014 were reviewed for demographics, pre-operative features, and perioperative outcomes.All parameters were tabulated and mean values were calculated.Student's t-test was utilized with p < 0.05 deemed significant.Details regarding surgical technique were reviewed and highlighted.Results: Fifteen patients underwent RALSSP during this period.Mean age of these men was 69 years.Mean body mass index (BMI) was 28.5 kg/m2.American Society of Anesthesiologists (ASA) score was on average 2.4.Average international prostate symptom score (IPSS) was 16.2 with the majority of men experiencing some adverse clinical sequela of such benign prostatic hyperplasia (BPH).For those patients not in retention, preoperative post-void residual (PVR) was 428 mL.All patients underwent successful RALSSP without need for conversion or need for blood transfusion.Mean estimated blood loss (EBL) was 290 mL.Five patients underwent other concurrent procedures (e.g.cystolithotomy).Mean length of hospital stay (LOS) was 2.4 days and only five patients required continuous bladder irrigation (CBI) postoperatively.Postoperative PVR improved to a mean of 33 mL and IPSS improved to 4.5 (p < 0.001).No major complications were identified.Adaptation of low transverse cystotomy, utilization of a robotic tenaculum in the #3 arm with its control by a surgeon on a second console, and the utilization of mucosal advancement have all subjectively aided in performance of RALSSP and perioperative outcomes.Conclusion: RALSSP allows for feasible performance of prostate adenoma enucleation with low risk of blood transfusion, short LOS, and significant improvement in IPSS and PVR; all while maintaining a minimally invasive approach.The use of a robotic tenaculum controlled by the secondary console and the mucosal advancement facilitate excellent outcomes and may play a role in minimizing hematuria and need for CBI.
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Sammy E. Elsamra
Nikhil Gupta
Haris Ahmed
David Leavitt
Jessica Kreshover
Louis Kavoussi
Lee Richstone
关键词:  Robotic assisted laparoscopic simple suprapubic prostatectomy  Benign prostatic hyperplasia  Blood loss  Hospital stay    
Abstract: Objective: Despite a multitude of minimally invasive surgical options available for benign prostatic enlargement, open simple prostatectomy (OSP) remains the standard for large prostates (typically greater than 100 g).OSP, however, is associated with significant morbidity.Recently, a few reports touting robotic application to simple prostatectomy have been published.Herein, we reviewed our series of robotic assisted laparoscopic simple suprapubic prostatectomy (RALSSP) and detailed modifications in our technique as our experience increased.Methods: All RALSSP cases performed between January 2013 and January 2014 were reviewed for demographics, pre-operative features, and perioperative outcomes.All parameters were tabulated and mean values were calculated.Student's t-test was utilized with p < 0.05 deemed significant.Details regarding surgical technique were reviewed and highlighted.Results: Fifteen patients underwent RALSSP during this period.Mean age of these men was 69 years.Mean body mass index (BMI) was 28.5 kg/m2.American Society of Anesthesiologists (ASA) score was on average 2.4.Average international prostate symptom score (IPSS) was 16.2 with the majority of men experiencing some adverse clinical sequela of such benign prostatic hyperplasia (BPH).For those patients not in retention, preoperative post-void residual (PVR) was 428 mL.All patients underwent successful RALSSP without need for conversion or need for blood transfusion.Mean estimated blood loss (EBL) was 290 mL.Five patients underwent other concurrent procedures (e.g.cystolithotomy).Mean length of hospital stay (LOS) was 2.4 days and only five patients required continuous bladder irrigation (CBI) postoperatively.Postoperative PVR improved to a mean of 33 mL and IPSS improved to 4.5 (p < 0.001).No major complications were identified.Adaptation of low transverse cystotomy, utilization of a robotic tenaculum in the #3 arm with its control by a surgeon on a second console, and the utilization of mucosal advancement have all subjectively aided in performance of RALSSP and perioperative outcomes.Conclusion: RALSSP allows for feasible performance of prostate adenoma enucleation with low risk of blood transfusion, short LOS, and significant improvement in IPSS and PVR; all while maintaining a minimally invasive approach.The use of a robotic tenaculum controlled by the secondary console and the mucosal advancement facilitate excellent outcomes and may play a role in minimizing hematuria and need for CBI.
Key words:  Robotic assisted laparoscopic simple suprapubic prostatectomy    Benign prostatic hyperplasia    Blood loss    Hospital stay
收稿日期:  2014-07-15      修回日期:  2014-08-29           出版日期:  2014-10-01      发布日期:  2014-10-28      整期出版日期:  2014-10-01
引用本文:    
Sammy E. Elsamra, Nikhil Gupta, Haris Ahmed, David Leavitt, Jessica Kreshover, Louis Kavoussi, Lee Richstone. Robotic assisted laparoscopic simple suprapubic prostatectomy—The Smith Institute for urology experience with an evolving technique[J]. Asian Journal of Urology, 2014, 1(1): 52-56.
Sammy E. Elsamra, Nikhil Gupta, Haris Ahmed, David Leavitt, Jessica Kreshover, Louis Kavoussi, Lee Richstone. Robotic assisted laparoscopic simple suprapubic prostatectomy—The Smith Institute for urology experience with an evolving technique. Asian Journal of Urology, 2014, 1(1): 52-56.
链接本文:  
http://www.ajurology.com/CN/  或          http://www.ajurology.com/CN/Y2014/V1/I1/52
[1] Bhojani N, Gandaglia G, Sood A, Rai A, Pucheril D, Chang SL,et al. Morbidity and mortality after benign prostatic hyperplasiasurgery: data from the american college of surgeons national surgicalquality improvement program. J Endourol 2014; 28: 831-40.
[2] Health Quality Ontario. Energy delivery systems for treatment ofbenign prostatic hyperplasia: an evidence-based analysis. Ont HealthTechnol Assess Ser 2006; 6: 1-121.
[3] Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, OliveiraAG. Prostatic arterial embolization to treat benign prostatichyperplasia. J Vasc Interv Radiol 2011; 22: 11-9.
[4] Suer E, Gokce I, Yaman O, Anafarta K, Gö?ü? O. Openprostatectomy is still a valid option for large prostates: a highvolume,single-center experience. Urology 2008; 72: 90-4.
[5] Vora A, Mittal S, Hwang J, Bandi G. Robot-assisted simpleprostatectomy: multi-institutional outcomes for glands larger than100 grams. J Endourol 2012; 26: 499-502.
[6] Weiss BE, Wein AJ, Malkowicz SB, Guzzo TJ. Comparison ofprostate volume measured by transrectal ultrasound and magneticresonance imaging: is transrectal ultrasound suitable to determinewhich patients should undergo active surveillance? Urol Oncol2013; 31: 1436-40.
[7] Mariano MB, Graziottin TM, Tefilli MV. Laparoscopicprostatectomy with vascular control for benign prostatic hyperplasia.J Urol 2002; 167: 2528-9.
[8] McCullough TC, Heldwein FL, Soon SJ, Galiano M, BarretE, Cathelineau X, et al. Laparoscopic versus open simpleprostatectomy: an evaluation of morbidity. J Endourol 2009; 23:129-33.
[9] Sotelo R, Clavijo R, Carmona O, Garcia A, Banda E, Miranda M, etal. Robotic simple prostatectomy. J Urol 2008; 179: 513-5.
[10] John H, Bucher C, Engel N, Fischer B, Fehr JL. Preperitonealrobotic prostate adenomectomy. Urology 2009; 73: 811-5.
[11] Uffort EE. Robotic-assisted laparoscopic simple prostatectomy: analternative minimal invasive approach for prostate adenoma. J RobotSurg 2010; 4: 7-10.
[12] Sutherland DE, Perez DS, Weeks DC. Robot-assisted simpleprostatectomy for severe benign prostatic hyperplasia. J Endourol2011; 25: 641-4.
[13] Coelho RF, Chauhan S, Sivaraman A, Palmer KJ, Orvieto MA,Rocco B, et al. Modified technique of robotic-assisted simpleprostatectomy: advantages of a vesico-urethral anastomosis. BJU Int2012; 109: 426-33.
[14] Matei DV, Brescia A, Mazzoleni F, Spinelli M, Musi G, MelegariS, et al. Robot-assisted simple prostatectomy (RASP): does it makesense? BJU Int 2012; 110(11 Pt C): E972-9.
[15] Leslie S, de Castro Abreu AL, Chopra S, Ramos P, Park D, BergerAK, et al. Transvesical robotic simple prostatectomy: initial clinicalexperience. Eur Urol 2014; pii: S0302-2838(13)01381-X. doi:10.1016/j.eururo.2013.12.020. [Epub ahead of print]
[1] Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158-163.
[2] Farhad Fakhrudin Vasanwala, Michael Yuet Chen Wong, Henry Sun Sien Ho, Keong Tatt Foo. Benign prostatic hyperplasia and male lower urinary symptoms:A guide for family physicians[J]. Asian Journal of Urology, 2017, 4(3): 181-184.
[3] Keong Tatt Foo. Pathophysiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 152-157.
[4] Kok Bin Lim. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 148-151.
[5] Kok Kit Ng, Foo Cheong Ng. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men[J]. Asian Journal of Urology, 2017, 4(3): 191-194.
[6] Rajeev Thekumpadam Puthenveetil, Debajit Baishya, Sasanka Barua, Debanga Sarma. Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management[J]. Asian Journal of Urology, 2015, 2(4): 233-237.
[1] Zhixiang Wang, Bing Liu, Xiaofeng Gao, Yi Bao, Yang Wang, Huamao Ye, Yinghao Sun, Linhui Wang. Laparoscopic ureterolysis with simultaneous ureteroscopy and percutaneous nephroscopy for treating complex ureteral obstruction after failed endoscopic intervention: A technical report[J]. Asian Journal of Urology, 2015, 2(4): 238 -243 .
[2] Louis R. Kavoussi. News from leading international academic urology departments[J]. Asian Journal of Urology, 2017, 4(1): 1 -2 .
[3] Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158 -163 .
[4] Cheuk Fan Shum, Weida Lau, Chang Peng Colin Teo. Medical therapy for clinical benign prostatic hyperplasia:a1 Antagonists, 5a reductase inhibitors and their combination[J]. Asian Journal of Urology, 2017, 4(3): 185 -190 .
[5] Foo Keong Tatt. Current consensus and controversies on male LUTS/BPH (part two)[J]. Asian Journal of Urology, 2018, 5(1): 8 -9 .
[6] Rishi R. Sekar, Claire M. De La Calle, Dattatraya Patil, Sarah A. Holzman, Yoram Baum, Umer Sheikh, Jonathan H. Huang, Adeboye O. Osunkoya, Brian P. Pollack, Haydn T. Kissick, Kenneth Ogan, Viraj A. Master. Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival[J]. Asian Journal of Urology, 2016, 3(2): 75 -81 .
[7] Ryan Yu, Jefferson Terry, Mutaz Alnassar, Jorge Demaria. Pediatric fibrous pseudotumor of the tunica vaginalis testis[J]. Asian Journal of Urology, 2016, 3(2): 99 -102 .
[8] Aso Omer Rashid, Saman Salih Fakhulddin. Risk factors for fever and sepsis after percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2016, 3(2): 82 -87 .
[9] Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26 -32 .
[10] Aldamanhori Reem,I.Osman Nadir,R.Chapple Christopher. Underactive bladder: Pathophysiology and clinical significance[J]. Asian Journal of Urology, 2018, 5(1): 17 -21 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed